Showing session: reset
Transformative Clinical Trials in Breast Cancer
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Primary analysis of the EORTC 10041/ BIG 3-04 MINDACT study: a prospective, randomized study evaluating the clinical utility of the 70-gene signature (MammaPrint) combined with common clinical-pathological criteria for selection of patients for adjuvant chemotherapy in breast cancer with 0 to 3 positive nodes
Martine Piccart
Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Free
- slides video
- audio + slides
- All slides included
Discussant
Harold J Burstein
Dana-Farber Cancer Institute, Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Anti-proliferative response and predictive biomarkers to palbociclib in early breast cancer: The Preoperative Palbociclib (POP) randomized trial
Monica Arnedos
Institut Gustave Roussy, Villejuif, France
- Free
- slides video
- audio + slides
- All slides included
Discussant
Nancy E. Davidson
University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Efficacy of T-DM1+pertuzumab over standard therapy for HER2+ breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
Angela M DeMichele
University of Pennsylvania, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Discussant
Mark D Pegram
UCLA School of Medicine, Los Angeles, CA, United States
- Permission not
granted for presentation
Low-fat dietary pattern and breast cancer mortality in the Women's Health Initiative (WHI) randomized trial
Rowan T Chlebowski
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States